研究目的
To develop a theranostic nanoplatform for NIR-II PA imaging-guided chemo-immunotherapy by taking advantage of the dual pH and redox responsive AuNNP@SN38/BLZ-945 Ve.
研究成果
The AuNNP@SN38/BLZ-945 Ve is a superior dual-responsive nanoplatform for drug delivery and biological imaging, effectively inhibiting both primary and metastatic tumors and prolonging the survival rate of the tumor-bearing mice.
研究不足
The technical and application constraints of the experiments, as well as potential areas for optimization, were not explicitly mentioned in the paper.
1:Experimental Design and Method Selection:
The responsive vesicle was prepared by self-assembly of nanogapped gold nanoparticles (AuNNPs) grafted with poly(ethylene glycol) (PEG) and dual pH/GSH-responsive polyprodrug poly(SN38-co-4-vinyl pyridine) (termed as AuNNP@PEG/PSN38VP).
2:Sample Selection and Data Sources:
The immune inhibitor BLZ-945 was encapsulated into the vesicles.
3:List of Experimental Equipment and Materials:
Gold nanoparticles, poly(ethylene glycol) (PEG), poly(SN38-co-4-vinyl pyridine) (PSN38VP), BLZ-
4:Experimental Procedures and Operational Workflow:
9 The vesicles were fabricated by self-assembly of amphiphilic AuNNP grafted with hydrophilic PEG and dual pH and redox-response copolymerized prodrug PSN38VP.
5:Data Analysis Methods:
The therapeutic efficacy was evaluated by measuring tumor volume and survival rates, and the immune response was analyzed by flow cytometry.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容